Steven Sexton

Statistics

Publications

Citations

204

H-Index

Active since

2020

Affiliations

Integrated DNA Technologies (United States)(Current)

University of California, Merced

Editas Medicine (United States)

Steven Sexton is an author at Integrated DNA Technologies (United States) specializing in cell therapy, gene editing for cell therapy, and therapeutic genome editing.

Publications per year

2020–2021

Publications

AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

Liyang Zhang, John A. Zuris, Ramya Viswanathan et al. · Nature Communications · 2021 · 172 citations · Full text

Life Sciences, Biotechnology, Oncology +15

Deletion of CISH and TGFβR2 in iPSC-Derived NK Cells Promotes High Cytotoxicity and Enhances <i>In Vivo</i> Tumor Killing

Alexandra Gerew, Steven Sexton, Kevin Wasko et al. · Blood · 2021 · 12 citations

Medicine, Cancer Biology, Immunology +10

How old is too old? <i>In vivo</i> engraftment of human peripheral blood stem cells cryopreserved for up to 18 years - implications for clinical transplantation and stability programs

John S. Underwood, Mahvish Q. Rahim, Carijo West et al. · World Journal of Stem Cells · 2020 · 10 citations · Full text

Pharmacy, Cell Biology, Cell Therapy +14

Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

Liyang Zhang, John A. Zuris, Ramya Viswanathan et al. · Nature Communications · 2021 · 10 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +5

1–4 of 4